Clinical Trial: Direct Pulp Capping With Biodentine in Permanent Teeth With Reversible Pulpitis

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07834424) titled 'Direct Pulp Capping With Biodentine in Permanent Teeth With Reversible Pulpitis' on Sept. 11.

Brief Summary: This study evaluates the clinical and radiographic outcomes of direct pulp capping using Biodentine (Septodont, Saint-Maur-des-Fosses, France), a calcium silicate-based cement, in mature permanent teeth diagnosed with reversible pulpitis following carious or mechanical pulp exposure. Biodentine was placed as a full-thickness (bulk) capping and interim restoration, with a definitive composite restoration completed at a later visit. Pulp vitality, postoperative pain, and radiographic healing are assessed over a 6-month follow-...